טבע מפרסמת את תוצאות הרבעון השני לשנת 2019 false
טבע תעשיות פרמצבטיות בע"מ 2 380
TEVA- PHARMACEUTICAL INDUSTRIES LTD
Corporation no: 520013954 10817

Israel Securities Authority   Tel Aviv Stock Exchange   C002 ( Public )   Reported via MAGNA: 07/08/2019
  www.isa.gov.il     www.tase.co.il       Reference: 2019-02-082120 Time of broadcast: 12:29 12:27:03

Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on

PR_document_and_tables_Q2_2019_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
       

Stock Exchange/Market: NYSE Date of revision of form structure: 06/08/2019
Address: P.O.B 3190 , Petach Tikva 49131   , Tel: 03-9267267 , 03-9267652 Fax: 03-9267519
E-mail address: tomer.amitai@teva.co.il  

Previous names of reporting entity:

Name of the Signatory: Beck Codner Iris Position of Signatory in the reporting corporation: Vice President, Global Corporate Communication Name of Employer Company:
Address: Basel 5 , Petach Tikva 49131 Telephone: 03-9267208 Facsimile: 03-9267851 E-mail: iris.beckcodner@teva.co.il 1